Method Comparison Between ELISAs Suggests Therapeutic Ranges for Infliximab Should Be Assay-Specific
J Appl Lab Med
.
2018 Nov 1;3(3):515-517.
doi: 10.1373/jalm.2018.027136.
Authors
Mandy H Perry
,
Timothy J McDonald
1
Affiliation
1
Royal Devon and Exeter National Health Service Foundation Trust, Exeter, UK.
PMID:
33636917
DOI:
10.1373/jalm.2018.027136
No abstract available